About AGI Therapeutics
AGI Therapeutics is a company based in Dublin (Ireland) founded in 2005 was acquired by Aravis in January 2012. AGI Therapeutics operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AGI Therapeutics
Detailed funding history for AGI Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AGI Therapeutics
AGI Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Aravis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth capital is provided by Aravis for Swiss high-tech companies.
|
Locked | Locked | Locked |
Investor details for AGI Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AGI Therapeutics
Investment portfolio details for AGI Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AGI Therapeutics
Detailed financials for AGI Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Agi Therapeutics Comparisons
Peer comparison for AGI Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AGI Therapeutics
AGI Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Protein biologics are developed for treating rare diseases.
|
|
| Locked | Locked | Locked |
Precision medicines for lung-related diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of inflammatory and rare diseases
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
|
|
| Locked | Locked | Locked |
Therapies for respiratory-related cardiopulmonary disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of respiratory diseases
|
Detailed competitors of AGI Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Agi Therapeutics
Complete news archive for AGI Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AGI Therapeutics
AGI Therapeutics was founded in 2005.
AGI Therapeutics is headquartered in Dublin, Ireland.
AGI Therapeutics was founded in 2005 in Dublin, Ireland, as a specialty pharmaceutical company focused on treatments for lung-related conditions. Operations center on developing targeted drug delivery systems, with the lead candidate AGI-350 undergoing preclinical testing for direct lung administration. Data related to AGI-001, s-pindolol, is licensed from external sources. The company went public in 2006 and was later acquired by Aravis, a member of Vidara Therapeutics.
AGI Therapeutics's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.
AGI Therapeutics has 1 investor. Key investors include Aravis.